STAAR Surgical Company (STAA) is priced at $61.04 after the most recent trading session. Recently in News on November 17, 2022, STAAR Surgical Opens EVO Experience Center in United States. Facility Now Serves as a Dynamic Hub of the EVO Lens-Based Experience for Ophthalmic Surgeons, Staff and Healthcare Practitioners. You can read further details here
STAAR Surgical Company had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $112.27 on 08/12/22, with the lowest value was $49.03 for the same time period, recorded on 05/12/22.
STAAR Surgical Company (STAA) full year performance was -41.01%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, STAAR Surgical Company shares are logging -45.63% during the 52-week period from high price, and 24.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $49.03 and $112.27.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 354526 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the STAAR Surgical Company (STAA) recorded performance in the market was -33.14%, having the revenues showcasing -41.32% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.95B, as it employees total of 692 workers.
The Analysts eye on STAAR Surgical Company (STAA)
During the last month, 0 analysts gave the STAAR Surgical Company a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 78.92, with a change in the price was noted -15.14. In a similar fashion, STAAR Surgical Company posted a movement of -19.87% for the period of last 100 days, recording 453,940 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for STAA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of STAAR Surgical Company (STAA)
Raw Stochastic average of STAAR Surgical Company in the period of last 50 days is set at 8.98%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 19.36%. In the last 20 days, the company’s Stochastic %K was 15.49% and its Stochastic %D was recorded 14.69%.
Considering, the past performance of STAAR Surgical Company, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -33.14%. Additionally, trading for the stock in the period of the last six months notably improved by 2.47%, alongside a downfall of -41.01% for the period of the last 12 months. The shares increased approximately by -4.27% in the 7-day charts and went up by -14.71% in the period of the last 30 days. Common stock shares were lifted by -41.32% during last recorded quarter.